Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
About this item
Full title
Author / Creator
Kotani, Daisuke , Oki, Eiji , Nakamura, Yoshiaki , Yukami, Hiroki , Mishima, Saori , Bando, Hideaki , Shirasu, Hiromichi , Yamazaki, Kentaro , Watanabe, Jun , Kotaka, Masahito , Hirata, Keiji , Akazawa, Naoya , Kataoka, Kozo , Sharma, Shruti , Aushev, Vasily N. , Aleshin, Alexey , Misumi, Toshihiro , Taniguchi, Hiroya , Takemasa, Ichiro , Kato, Takeshi , Mori, Masaki and Yoshino, Takayuki
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Despite standard-of-care treatment, more than 30% of patients with resectable colorectal cancer (CRC) relapse. Circulating tumor DNA (ctDNA) analysis may enable postsurgical risk stratification and adjuvant chemotherapy (ACT) treatment decision-making. We report results from GALAXY, which is an observational arm of the ongoing CIRCULATE-Japan study...
Alternative Titles
Full title
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Authors, Artists and Contributors
Author / Creator
Oki, Eiji
Nakamura, Yoshiaki
Yukami, Hiroki
Mishima, Saori
Bando, Hideaki
Shirasu, Hiromichi
Yamazaki, Kentaro
Watanabe, Jun
Kotaka, Masahito
Hirata, Keiji
Akazawa, Naoya
Kataoka, Kozo
Sharma, Shruti
Aushev, Vasily N.
Aleshin, Alexey
Misumi, Toshihiro
Taniguchi, Hiroya
Takemasa, Ichiro
Kato, Takeshi
Mori, Masaki
Yoshino, Takayuki
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873552
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873552
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/s41591-022-02115-4
